Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Clinical Trial of DS-7423 in Japanese Patients With Advanced Solid Tumors
jRCT2080221724Phase 1
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of DS-7423 in Nonhematologic neoplasms, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Safety and tolerability of DS-7423 and Pharmacokinetics of DS-7423.
02
Drugs
DS-7423
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080221724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221724.